Published in J Oncol on June 28, 2010
Breaking the 'harmony' of TNF-α signaling for cancer treatment. Oncogene (2011) 0.92
Putative role of HIF transcriptional activity in melanocytes and melanoma biology. Dermatoendocrinol (2013) 0.92
Differential sex-specific effects of oxygen toxicity in human umbilical vein endothelial cells. Biochem Biophys Res Commun (2017) 0.77
Beyond Telomerase: Telomere Instability as a Novel Target for Cancer Therapy. J Mol Genet Med (2013) 0.75
Treating Cancer by Targeting Telomeres and Telomerase. Antioxidants (Basel) (2017) 0.75
Means to the ends: The role of telomeres and telomere processing machinery in metastasis. Biochim Biophys Acta (2016) 0.75
Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science (2005) 23.44
Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science (1997) 15.48
Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell (1996) 9.10
Angiogenesis. Annu Rev Med (2006) 6.94
Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature (2007) 6.82
Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors. Cancer Res (2004) 5.65
Protection of mammalian telomeres. Oncogene (2002) 5.38
SOS repair hypothesis: phenomenology of an inducible DNA repair which is accompanied by mutagenesis. Basic Life Sci (1975) 4.17
Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res (1998) 3.79
Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev (2001) 3.41
Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal (2007) 3.36
Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp Med (1994) 3.09
Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies. Cancer Res (2005) 3.00
Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action. Exp Cell Res (2005) 2.62
The Werner syndrome helicase and exonuclease cooperate to resolve telomeric D loops in a manner regulated by TRF1 and TRF2. Mol Cell (2004) 2.60
Transcriptional regulation of the Vascular Endothelial Growth Factor gene--a concert of activating factors. Cardiovasc Res (2005) 2.52
Sonic hedgehog myocardial gene therapy: tissue repair through transient reconstitution of embryonic signaling. Nat Med (2005) 2.24
VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J (2006) 2.20
Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias. Proc Natl Acad Sci U S A (2001) 1.90
Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene (1997) 1.85
Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF. Proc Natl Acad Sci U S A (2006) 1.66
Rapid inhibition of cancer cell growth induced by lentiviral delivery and expression of mutant-template telomerase RNA and anti-telomerase short-interfering RNA. Cancer Res (2004) 1.66
Angiopoietins in tumours: the angiogenic switch. J Pathol (2004) 1.60
Vascular endothelial growth factor family of ligands and receptors: review. Blood Cells Mol Dis (2007) 1.56
Tumor necrosis factor-alpha receptor p75 is required in ischemia-induced neovascularization. Circulation (2007) 1.51
Etk/Bmx transactivates vascular endothelial growth factor 2 and recruits phosphatidylinositol 3-kinase to mediate the tumor necrosis factor-induced angiogenic pathway. J Biol Chem (2003) 1.46
Lectin histochemistry of mammalian endothelium. Histochemistry (1987) 1.46
Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis. Cancer Res (2001) 1.46
Gene expression changes in response to E2F1 activation. Nucleic Acids Res (2002) 1.44
Evidence that exposure of the telomere 3' overhang sequence induces senescence. Proc Natl Acad Sci U S A (2003) 1.37
Enhancement of DNA repair in human skin cells by thymidine dinucleotides: evidence for a p53-mediated mammalian SOS response. Proc Natl Acad Sci U S A (1997) 1.33
Experimental elongation of telomeres extends the lifespan of immortal x normal cell hybrids. EMBO J (1996) 1.23
Telomere 3' overhang-specific DNA oligonucleotides induce autophagy in malignant glioma cells. FASEB J (2007) 1.22
Overexpression of p27(Kip1) by doxycycline-regulated adenoviral vectors inhibits endothelial cell proliferation and migration and impairs angiogenesis. FASEB J (2001) 1.21
Telomere-based DNA damage responses: a new approach to melanoma. FASEB J (2004) 1.21
Vascular endothelial growth factor induction by prostaglandin E2 in human airway smooth muscle cells is mediated by E prostanoid EP2/EP4 receptors and SP-1 transcription factor binding sites. J Biol Chem (2005) 1.19
The "chemoinvasion assay": a tool to study tumor and endothelial cell invasion of basement membranes. Int J Dev Biol (2004) 1.15
Induction of apoptosis by telomere 3' overhang-specific DNA. Exp Cell Res (2002) 1.14
Telomere homolog oligonucleotides induce apoptosis in malignant but not in normal lymphoid cells: mechanism and therapeutic potential. Int J Cancer (2009) 1.08
Telomeric DNA induces apoptosis and senescence of human breast carcinoma cells. Breast Cancer Res (2007) 1.06
Signaling pathway requirements for induction of senescence by telomere homolog oligonucleotides. Exp Cell Res (2004) 1.05
Induction of a p95/Nbs1-mediated S phase checkpoint by telomere 3' overhang specific DNA. FASEB J (2003) 1.04
A role for WRN in telomere-based DNA damage responses. Proc Natl Acad Sci U S A (2006) 1.03
Oxidized low-density lipoproteins inhibit endothelial cell proliferation by suppressing basic fibroblast growth factor expression. Circulation (2000) 1.02
Molecular design and clinical development of VEGFR kinase inhibitors. Curr Top Med Chem (2007) 0.99
New paradigm for vessel intravasation by tumor cells. Am J Pathol (2002) 0.98
Nuclease resistance of telomere-like oligonucleotides monitored in live cells by fluorescence anisotropy imaging. Anal Chem (2006) 0.97
Early effects of hypoxia/reoxygenation on VEGF, ang-1, ang-2 and their receptors in the rat myocardium: implications for myocardial angiogenesis. Mol Cell Biochem (2000) 0.97
Expression of the vascular endothelial growth factor gene is inhibited by p73. Oncogene (2000) 0.97
T-oligo treatment decreases constitutive and UVB-induced COX-2 levels through p53- and NFkappaB-dependent repression of the COX-2 promoter. J Biol Chem (2005) 0.96
Hypoxia and vascular endothelial growth factor acutely up-regulate angiopoietin-1 and Tie2 mRNA in bovine retinal pericytes. Microvasc Res (2003) 0.95
Features that determine telomere homolog oligonucleotide-induced therapeutic DNA damage-like responses in cancer cells. J Cell Physiol (2007) 0.93
Stimulation of melanogenesis by DNA oligonucleotides: effect of size, sequence and 5' phosphorylation. J Dermatol Sci (2001) 0.92
DNA oligonucleotide treatment corrects the age-associated decline in DNA repair capacity. FASEB J (2002) 0.92
Nucleophosmin/B23 regulates transcriptional activation of E2F1 via modulating the promoter binding of NF-kappaB, E2F1 and pRB. Cell Signal (2006) 0.89
T-oligos augment UV-induced protective responses in human skin. FASEB J (2006) 0.86
Cancer gene therapy targeting angiogenesis: an updated review. World J Gastroenterol (2006) 0.85
The tale of the telomere: implications for prevention and treatment of skin cancers. J Investig Dermatol Symp Proc (2005) 0.84
Thymidine dinucleotide mimics the effect of solar simulated irradiation on p53 and p53-regulated proteins. J Invest Dermatol (1999) 0.84
Organ-specific metastases in immunodeficient mice injected with human melanoma cells: a quantitative pathological analysis. Melanoma Res (1993) 0.80
Angiopoietin-1, angiopoietin-2 and Tie-2 in tumour and non-tumour tissues during growth of experimental melanoma. Melanoma Res (2001) 0.75
Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest (2005) 3.61
Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation (2007) 2.88
Netrins promote developmental and therapeutic angiogenesis. Science (2006) 2.83
Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression. Circ Res (2009) 2.82
Exosomes from human CD34(+) stem cells mediate their proangiogenic paracrine activity. Circ Res (2011) 2.31
A call for the development and implementation of a targeted national melanoma screening program. Arch Dermatol (2006) 2.29
Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am J Pathol (2007) 2.27
Sonic hedgehog myocardial gene therapy: tissue repair through transient reconstitution of embryonic signaling. Nat Med (2005) 2.24
Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction. Circulation (2006) 2.02
Academic dermatology manpower: issues of recruitment and retention. Arch Dermatol (2007) 2.02
IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. Circ Res (2008) 2.01
Interleukin-10 deficiency impairs bone marrow-derived endothelial progenitor cell survival and function in ischemic myocardium. Circ Res (2011) 1.99
Topical sonic hedgehog gene therapy accelerates wound healing in diabetes by enhancing endothelial progenitor cell-mediated microvascular remodeling. Circulation (2006) 1.91
Melanoma incidence and mortality among US whites, 1969-1999. JAMA (2002) 1.74
Sonic hedgehog-modified human CD34+ cells preserve cardiac function after acute myocardial infarction. Circ Res (2012) 1.70
Sunlight, tanning booths, and vitamin D. J Am Acad Dermatol (2005) 1.68
Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF. Proc Natl Acad Sci U S A (2006) 1.66
The vitamin D questions: how much do you need and how should you get it? J Am Acad Dermatol (2006) 1.66
Endothelial progenitor thrombospondin-1 mediates diabetes-induced delay in reendothelialization following arterial injury. Circ Res (2006) 1.63
CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction. Proc Natl Acad Sci U S A (2010) 1.61
Functional disruption of alpha4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization. J Exp Med (2006) 1.56
CXC-chemokine receptor 4 antagonist AMD3100 promotes cardiac functional recovery after ischemia/reperfusion injury via endothelial nitric oxide synthase-dependent mechanism. Circulation (2012) 1.53
Ultraviolet-fluorescent tattoo location of cutaneous biopsy site. Dermatol Surg (2011) 1.51
Tumor necrosis factor-alpha receptor p75 is required in ischemia-induced neovascularization. Circulation (2007) 1.51
IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression. FASEB J (2006) 1.50
Visual screening for malignant melanoma: a cost-effectiveness analysis. Arch Dermatol (2007) 1.41
Targeted Inhibition of Leucine-Rich Repeat and Immunoglobulin Domain-Containing Protein 1 in Transplanted Neural Stem Cells Promotes Neuronal Differentiation and Functional Recovery in Rats Subjected to Spinal Cord Injury. Crit Care Med (2016) 1.40
Pitfalls of evidence-based medicine: the example of actinic keratosis therapy. Arch Dermatol (2012) 1.40
Evidence that exposure of the telomere 3' overhang sequence induces senescence. Proc Natl Acad Sci U S A (2003) 1.37
Lipopolysaccharide stimulation of ERK1/2 increases TNF-alpha production via Egr-1. Am J Physiol Cell Physiol (2002) 1.37
Chronic ethanol increases lipopolysaccharide-stimulated Egr-1 expression in RAW 264.7 macrophages: contribution to enhanced tumor necrosis factor alpha production. J Biol Chem (2002) 1.31
Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy. Circulation (2005) 1.28
Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction. Circ Res (2013) 1.27
Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia/reperfusion injury. Biochem Biophys Res Commun (2013) 1.27
Noggin overexpression inhibits eyelid opening by altering epidermal apoptosis and differentiation. EMBO J (2003) 1.27
The cytoskeletal protein ezrin regulates EC proliferation and angiogenesis via TNF-alpha-induced transcriptional repression of cyclin A. J Clin Invest (2005) 1.26
Cell-free embryonic stem cell extract-mediated derivation of multipotent stem cells from NIH3T3 fibroblasts for functional and anatomical ischemic tissue repair. Circ Res (2008) 1.25
Modulation of BMP signaling by noggin is required for induction of the secondary (nontylotrich) hair follicles. J Invest Dermatol (2002) 1.25
Amyloid beta binds trimers as well as monomers of the 75-kDa neurotrophin receptor and activates receptor signaling. J Biol Chem (2001) 1.23
Skin cancer prevention and detection practices among siblings of patients with melanoma. J Am Acad Dermatol (2003) 1.22
Telomere 3' overhang-specific DNA oligonucleotides induce autophagy in malignant glioma cells. FASEB J (2007) 1.22
Telomere-based DNA damage responses: a new approach to melanoma. FASEB J (2004) 1.21
Myocardial knockdown of mRNA-stabilizing protein HuR attenuates post-MI inflammatory response and left ventricular dysfunction in IL-10-null mice. FASEB J (2010) 1.16
CXCR4 antagonist AMD3100 accelerates impaired wound healing in diabetic mice. J Invest Dermatol (2011) 1.16
p75 Neurotrophin receptor antagonist retards apoptosis-driven hair follicle involution (catagen). J Invest Dermatol (2003) 1.16
CXCR4-mediated bone marrow progenitor cell maintenance and mobilization are modulated by c-kit activity. Circ Res (2010) 1.15
A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch Dermatol (2004) 1.14
Improving skin cancer prevention and detection education in US medical schools. Arch Dermatol (2006) 1.14
Induction of apoptosis by telomere 3' overhang-specific DNA. Exp Cell Res (2002) 1.14
Interleukin-10 treatment attenuates pressure overload-induced hypertrophic remodeling and improves heart function via signal transducers and activators of transcription 3-dependent inhibition of nuclear factor-κB. Circulation (2012) 1.14
Unity in action. J Invest Dermatol (2014) 1.12
MITF mediates cAMP-induced protein kinase C-beta expression in human melanocytes. Biochem J (2006) 1.11
Bone morphogenetic protein (BMP) signaling controls hair pigmentation by means of cross-talk with the melanocortin receptor-1 pathway. Proc Natl Acad Sci U S A (2004) 1.10
Fifty years of skin aging. J Investig Dermatol Symp Proc (2002) 1.10
Synergistic effect of combined intramyocardial CD34+ cells and VEGF2 gene therapy after MI. Nat Clin Pract Cardiovasc Med (2006) 1.09
Telomere homolog oligonucleotides induce apoptosis in malignant but not in normal lymphoid cells: mechanism and therapeutic potential. Int J Cancer (2009) 1.08
Polypodium leucotomos extract decreases UV-induced Cox-2 expression and inflammation, enhances DNA repair, and decreases mutagenesis in hairless mice. Am J Pathol (2009) 1.07
Sonic hedgehog induces angiogenesis via Rho kinase-dependent signaling in endothelial cells. J Mol Cell Cardiol (2010) 1.07